B Marescau
Overview
Explore the profile of B Marescau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Decaluwe R, Maes D, Cools A, Wuyts B, De Smet S, Marescau B, et al.
J Anim Sci
. 2014 Jul;
92(8):3557-67.
PMID: 24981570
Research showed a positive association between back fat (BF) change the week before farrowing and colostrum yield (CY). This study tested the causality of this association, hence to optimize CY...
2.
Gentens P, De Deyn P, DHooge R, Pei H, Tassignon M, Van Dromme S, et al.
Amino Acids
. 2013 Nov;
11(1):43-53.
PMID: 24178637
Glycine was intravenously injected in rabbits and resulted in a dose dependent hyperglycinemia. A dose of 10mmol/kg was sufficient to achieve plasma levels of 10 to 16mM comparable to serum...
3.
Lee E, Hu C, Bhargava R, Ponnusamy R, Park H, Novicoff S, et al.
Gene Ther
. 2013 Feb;
20(8):785-96.
PMID: 23388701
Complete arginase I deficiency is the least severe urea cycle disorder, characterized by hyperargininemia and infrequent episodes of hyperammonemia. Patients suffer from neurological impairment with cortical and pyramidal tract deterioration,...
4.
Torremans A, Marescau B, Kranzlin B, Gretz N, Billiouw J, Vanholder R, et al.
Kidney Int
. 2006 Apr;
69(11):2003-12.
PMID: 16641922
Polycystic kidney disease (PKD) accounts for 7-10% of all dialyzed renal insufficient patients. Accumulation of specific guanidino compounds (GCs) has been related to neurological, cardiovascular, hematological, and immunological complications of...
5.
van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn P
Amino Acids
. 2005 May;
28(4):377-87.
PMID: 15889219
A reliable extrapolation of neurochemical alterations from a mouse model to human metabolic brain disease requires knowledge of neurotransmitter levels and related compounds in control mouse brain. C57BL/6 is a...
6.
Engelborghs S, Vloeberghs E, Maertens K, Marescau B, De Deyn P
J Neurol Neurosurg Psychiatry
. 2004 Jun;
75(7):1080.
PMID: 15201387
No abstract available.
7.
Torremans A, DHooge R, Van de Vijver G, Marescau B, Vanholder R, Lameire N, et al.
Brain Res
. 2004 Apr;
1008(1):107-12.
PMID: 15081387
Uremic retention solutes possibly contribute to neuronal hypoxia/ischemia and its consequences in patients with renal failure. We examined the in vitro effects of several uremic retention solutes on murine central...
8.
Engelborghs S, Marescau B, De Deyn P
Neurochem Res
. 2003 Jul;
28(8):1145-50.
PMID: 12834252
To study changes in amino acid metabolism and biogenic amines in Parkinson's disease, we set up a prospective study and measured biogenic amines, their main metabolites, and 22 different amino...
9.
Torremans A, Marescau B, Vanholder R, De Smet R, Billiouw J, De Deyn P
Amino Acids
. 2003 May;
24(4):375-81.
PMID: 12768499
There are no reliable mean values of N(G)-monomethylarginine (NMMA) in blood and urine of patients with renal insufficiency available in the literature. Therefore we investigate whether the NMMA levels are...
10.
Al Banchaabouchi M, Marescau B, DHooge R, De Deyn P
Amino Acids
. 2002 Feb;
21(4):401-15.
PMID: 11858699
Nephrectomy in mice provokes a decrease in creatinine clearance (CTN(Cl)) and an increase in urea and specific guanidino compound (GC) concentrations in blood and other tissues. Our purpose was to...